
Hypercalcemia of malignancy in metastatic adenocarcinoma of left lower eyelid - A report of a rare case
Author(s) -
Divya Bm,
Shylashree,
Muthukumar Mani
Publication year - 2021
Publication title -
ip international journal of ocular oncology and oculoplasty/ip international journal of ocular oncology and oculoplasty
Language(s) - English
Resource type - Journals
eISSN - 2581-5016
pISSN - 2581-5024
DOI - 10.18231/j.ijooo.2021.042
Subject(s) - eyelid , medicine , malignancy , adenocarcinoma , basal cell carcinoma , radiation therapy , adenocarcinoma of the lung , dermatology , rare disease , stage (stratigraphy) , basal cell , metastasis , pathology , disease , surgery , cancer , paleontology , biology
Adenocarcinoma of eyelid is a rare disease with an incidence of 1 to 5.5% and is considered to be the most common eyelid malignancy following basal cell and squamous cell carcinoma. The symptoms usually present as swelling, thickening, change in appearance of the eyelid skin and ulceration. Various treatment modalities include surgery, radiation or chemotherapy relying upon the stage of tumor at the time of presentation. However, metastasis of adenocarcinoma of the eyelid to other organs is quite rare. We are presenting a case of a 35 year old male who initially presented with complaints of watering in the left eye and in due course, was diagnosed with adenocarcinoma of eyelid which was being treated and eventually progressed to lung and skeletal tissues. This gentleman also had severe Hypercalcemia which was secondary to paraneoplastic syndrome.